Slrn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Slrn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Slrn Today - Breaking & Trending Today

Acelyrin (NASDAQ:SLRN) Hits New 12-Month Low at $5.61

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $5.61 and last traded at $5.67, with a volume of 81890 shares changing hands. The stock had previously closed at $5.95. Wall Street Analysts Forecast Growth A number of research analysts have […] ....

Hidradenitis Suppurativa , Shao Lee Lin , Blue Owl Capital Holdings , Acelyrin Inc , Bio Partners , Wells Fargo Company , Vanguard Group Inc , Acelyrin Company Profile , Decheng Capital , Get Free Report , Lee Lin , Owl Capital Holdings , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn ,

Brokerages Set Acelyrin, Inc. (NASDAQ:SLRN) Target Price at $23.67

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among […] ....

Shao Lee Lin , Hidradenitis Suppurativa , Wells Fargo Company , Acelyrin Company Profile , Jpmorgan Chase Co , Morgan Stanley , Vanguard Group Inc , Jefferies Financial Group , Bio Partners , Ayurmaya Capital Management Company , Acelyrin Inc , Get Free Report , Financial Group , Lee Lin , Maya Capital Management Company , Get Free , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn ,

Acelyrin, Inc. (NASDAQ:SLRN) Given Consensus Recommendation of "Moderate Buy" by Analysts

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among […] ....

Hidradenitis Suppurativa , Shao Lee Lin , Jefferies Financial Group , Wells Fargo Company , Barclays Plc , Morgan Stanley , York Mellon Corp , Securities Exchange Commission , Marshall Wace , Driehaus Capital Management , Rafferty Asset Management , Acelyrin Inc , Get Free Report , Lee Lin , Exchange Commission , Asset Management , New York Mellon Corp , Get Free , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn ,

Acelyrin (NASDAQ:SLRN) Stock Price Down 8.6%

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) traded down 8.6% on Tuesday . The company traded as low as $7.62 and last traded at $7.63. 538,704 shares traded hands during trading, a decline of 49% from the average session volume of 1,052,227 shares. The stock had previously closed at $8.35. Analyst Upgrades and Downgrades A […] ....

Shao Lee Lin , Hidradenitis Suppurativa , Jefferies Financial Group , Morgan Stanley , Capital Management , Wells Fargo Company , Osaic Holdings Inc , Tower Research Capital , Acelyrin Inc , Get Free Report , Financial Group , Stock Down , Lee Lin , Research Capital , Strs Ohio , Psoriatic Arthritis , Acelyrin Daily , Nasdaq Slrn ,